February 9, 2011

The American Diabetes Association is working with an organization that offers free prescription drug savings cards to help increase access to diabetes medications.

February 2, 2011

Eli Lilly’s and Amylin Pharmaceuticals’ Type 2 diabetes drug, Bydureon, appears to work better at promoting weight loss than drugs made by Takeda and Merck, but it could face a challenger of its own.

January 27, 2011

Amylin Pharmaceuticals continued to experience losses in sales and profits during fourth quarter 2010 and for the year as a whole, but losses were lower than in 2009, according to financial results released by the drug maker Wednesday.

January 21, 2011

Obesity rates continue to soar among the U.S. population, particularly in children. And the result, the Centers for Disease Control and Prevention reported, leads both to “psychosocial problems and to cardiovascular risk factors, such as hypertension, high cholesterol and abnormal glucose tolerance or diabetes.”

January 18, 2011

The Food and Drug Administration has approved a generic diabetes drug made by Mylan, the drug maker said Tuesday.

January 7, 2011

A new oral treatment for Type 2 diabetes hit the shelves Friday.

January 5, 2011



Sales of diet-aid and weight-loss solutions for the past year have been relatively flat, but a confluence of factors — childhood obesity approaching “epidemic” status combined with the real need to reduce escalating healthcare costs connected to obesity — could become a real driver behind weight-loss products in the coming year. 


December 7, 2010

Supplier News — Fera Pharmaceuticals has recently launched two new topical ointments. The New York-based company has developed Ilotycin (erythromycin) and Garamycin (gentamicin) ophthalmic ointments, both for the treatment of bacterial infections of the eye. “Our goal is simple: to keep more quality healthcare choices alive for the people who need them,” company co-founder Frank DellaFera said.


December 2, 2010

A growing drug-treated population will cause the Type 2 diabetes drug market in China to increase to $2.5 billion by 2014 ...

November 17, 2010

A Type 2 diabetes drug marketed by Eli Lilly and Amylin Pharmaceuticals may lower the...

November 8, 2010

Two drug makers conducting a late-stage clinical trial of a drug for treating overweight and...

November 7, 2010

The Food and Drug Administration approved the first and only once-a-day metformin extended-release plus dipeptidyl...

November 7, 2010

A new study conducted by University of Toronto researchers found that GLP-1 analogues not only...

October 31, 2010

Supermarket chain Stater Bros. will mark National Diabetes Awareness Month by offering free diabetes drugs...

October 27, 2010

Many Type 2 diabetes patients who use the drug Onglyza (saxagliptin) switched to that drug...

October 6, 2010

Relatively healthy patients with Type 2 diabetes experienced a significant reduction in blood-sugar levels when...

September 22, 2010

The Food and Drug Administration has moved to significantly restrict access to a controversial diabetes...

September 19, 2010

An injected insulin made by French drug maker Sanofi-Aventis provided further reduction of blood sugar...

September 19, 2010

An investigational treatment made by French drug maker Sanofi-Aventis showed “significant” improvement in blood-glucose control...

September 16, 2010

The Food and Drug Administration said Friday it had begun a safety review of Takeda’s...

September 1, 2010

The National Center for Complementary and Alternative Medicine's small-business technology transfer program, part of the...

August 3, 2010

The number of states with an obesity prevalence of 30% or more tripled in two...

June 27, 2010

A recently approved drug for Type 2 diabetes made by Novo Nordisk worked better than...

June 20, 2010

Swiss drug maker Roche has started a risk-mitigation plan in the late-stage clinical trial of...